Adrenergic alpha-Antagonists

• 

  Subject Areas on Research

  • A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor. 
  • A new approach to the role of noradrenaline in learning: problem-solving in the marmoset after alpha-noradrenergic receptor blockade. 
  • A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine. 
  • Adjuvant therapy after surgical stone management. 
  • Adrenergic receptors: biochemistry, regulation, molecular mechanism, and clinical implications. 
  • Affinity chromatography of human platelet alpha 2-adrenergic receptors. 
  • Agonist versus antagonist binding to alpha-adrenergic receptors. 
  • Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development. 
  • Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding. 
  • Alpha1-adrenergic blockers and intraoperative floppy-iris syndrome. 
  • An analysis of the pulsatile hemodynamic responses of the pulmonary circulation to acute and chronic pulmonary venous hypertension in the awake dog. 
  • Analysis of responses to serotonin in the pulmonary vascular bed of the cat. 
  • Anisodamine at higher concentrations in inhibiting alpha-adrenergic responses in isolated canine blood vessels. 
  • Arylazide photoaffinity probe for alpha 2-adrenoceptors. 
  • Benign prostatic hyperplasia. New concepts in the 1990s. 
  • Benign prostatic hyperplasia: diagnosis and treatment. Benign Prostatic Hyperplasia Guideline Panel. Agency for Health Care Policy and Research. 
  • Beta-adrenergic receptors: recognition and regulation. 
  • Biochemical and radiohistochemical analyses of alpha-2 adrenergic receptors in the kindling model of epilepsy. 
  • Central regulation of photosensitive membrane turnover in the lateral eye of Limulus. I. Octopamine primes the retina for daily transient rhabdom shedding. 
  • Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. 
  • Characterization of alpha 2-adrenergic receptor subtype-specific antibodies. 
  • Clinical physiology of adrenergic receptor regulation. 
  • Cocaine augments contractility of the pregnant human uterus by both adrenergic and nonadrenergic mechanisms. 
  • Cultured human trabecular meshwork cells express functional alpha 2A adrenergic receptors. 
  • Determination of subtype selectivity of alpha-adrenergic antagonists: comparison of selective and nonselective radioligands. 
  • Direct binding studies of adrenergic receptors: biochemical, physiologic, and clinical implications. 
  • Dissociation of locomotor impairment from mydriasis evoked by clonidine injected into cat's rostral hypothalamus. 
  • Effect of autonomic blockade on the hemodynamic findings in acute cardiac tamponade. 
  • Effects of alpha 1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction. 
  • Effects of neurochemicals upon a dinoflagellate photoresponse. 
  • Epinephrine induces rapid deterioration in pulmonary oxygen exchange in intact, anesthetized rats: a flow and pulmonary capillary pressure-dependent phenomenon. 
  • Evidence that there is no direct correlation between alpha 2-adrenoceptor antagonism and inhibition of voltage-dependent sodium channels. 
  • Evolution of the clinical management of hypertension. Emerging role of "specific" vasodilators as initial therapy. 
  • Factors influencing the lipid response to selective alpha 1-inhibition. 
  • Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia. 
  • Hemodynamic and metabolic responses to exercise after adrenoceptor blockade in humans. 
  • Idazoxan blocks the nicotine-induced reversal of the memory impairment caused by the NMDA glutamate receptor antagonist dizocilpine. 
  • Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding. 
  • In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia. 
  • Inhibition of sympathetic pathways restores postoperative ileus in the upper and lower gastrointestinal tract. 
  • International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. 
  • Isolated beta-adrenergic binding sites: a potential assay vehicle for catecholamines. 
  • Magnesium dependence of agonist binding to adenylate cyclase-coupled hormone receptors. 
  • Magnitude of abdominal incision affects the duration of postoperative ileus in rats. 
  • Mechanisms of reflex bladder activation by pudendal afferents. 
  • Medical expulsive therapy for ureteral calculi in the real world: targeted education increases use and improves patient outcome. 
  • Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. 
  • Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells. 
  • Novel human alpha1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function. 
  • Pharmacological approach to functional reorganization: the role of norepinephrine. 
  • Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. 
  • Pharmacotherapy in stroke rehabilitation. 
  • Phentolamine for neurogenic pulmonary edema: bench to bedside progress. 
  • Possible difference in the sympathetic activation on extreme dippers with or without exaggerated morning surge. 
  • Postcoronary thrombolysis management. 
  • Postnatal development of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]HEAT in normal rats and rats treated with alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. 
  • Production of adrenergic receptors in yeast. 
  • Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin. 
  • Regulation of lipoprotein metabolism by adrenergic mechanisms. 
  • Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine. 
  • Role of alpha 1 adrenoceptors in the turnover of phosphatidylinositol and of alpha 2 adrenoceptors in the regulation of cyclic AMP accumulation in hamster adipocytes. 
  • Rostral hypothalamus: a new neuroanatomical site of neurochemically-induced emesis in the cat. 
  • Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle. 
  • Subclassification of alpha-adrenergic receptors by direct binding studies. 
  • Surgical autonomic denervation results in altered colonic motility: an explanation for low anterior resection syndrome? 
  • Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. 
  • Tamsulosin and the intraoperative floppy iris syndrome. 
  • Temperature immutability of adenyl cyclase-coupled beta adrenergic receptors. 
  • The effect of alpha1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy. 
  • The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. 
  • Transiently overexpressed alpha2-adrenoceptors and their control of DNA synthesis in the developing brain. 
  • Ureteral Stent-Associated Pain: A Review 
  • Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion. 
  • [3H]Dihydroergocryptine binding to alpha adrenergic receptors in canine aortic membranes. 
  • alpha-Adrenergic receptors in human adipocyte membranes: direct determination by [3H]yohimbine binding.